Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Productive Hands Free Evaporation
Friday, April 11, 2014
Rocket™ Evaporator from Genevac provides truly unattended operation capability.

New Metrohm Brochure and Website Pharmaceutical Analysis
Tuesday, April 08, 2014
Metrohm’s new brochure Pharmaceutical analysis is a highly valuable compendium to get an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.

KNF Lab’s RC900 Rotary Evaporator at Analytica 2014
Tuesday, March 25, 2014
An efficient, robust instrument set to transform rotary evaporation.

Optibrium and Integrated Chemistry Design Collaborate
Tuesday, March 25, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

Determining the Value of Waste Materials as Fuel Feedstock
Thursday, March 20, 2014
Model 440 CHN Elemental Analyzer used to determine percentage of CHN in a waste sample.

Optibrium, Integrated Chemistry Design Collaborate on New iPad App
Monday, March 17, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

Double O-ring Ensures High Integrity Cap Mat Seal
Thursday, March 13, 2014
New silicone cap mats from Porvair Sciences.

Xylem’s Bellingham + Stanley Launch High Specification Polarimeters
Wednesday, March 12, 2014
The ADP600 Series are high accuracy Peltier temperature-controlled polarimeters.

Exeter Analytical Launches Entry Level CHN Analyzer
Tuesday, March 04, 2014
Model 440 analyzer determines CHN percentage levels quickly, easily and reliably.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1275
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv